… and strong opioid medications.21 The experimental … analyses by excluding trials exhibiting substantial overall … trial of K1 acupoint acustimulation to prevent cisplatin-induced or oxaliplatin … three-step analgesic drug therapy for treatment of cancer pain …

… assessing cadonilimab following an ongoing trial evaluating the agent in … at the European Society for Medical Oncology (ESMO) Congress 2025 … 14 every 3 weeks and oxaliplatin at 130 mg/ … as first-line (1L) treatment for advanced gastric or gastroesophageal …

… FDA approved daratumumab and hyaluronidase-fihj (Darzalex Faspro; Janssen Biotech … for Medical Oncology Congress.8 The trial … oxaliplatin, and docetaxel (FLOT) chemotherapy as a neoadjuvant and adjuvant treatment … nsclc US FDA accepts new drug application …

… Food and Drug Administration (FDA) has accepted … progressed following treatment with a fluoropyrimidine, oxaliplatin, and … infection. Institute medical management promptly, including … : ONCOLOGY FDA HEALTH CLINICAL TRIALS PHARMACEUTICAL BIOTECHNOLOGY SOURCE: …

… . Nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin … survival, but randomized trials have failed to demonstrate … fluorouracil, leucovorin, and oxaliplatin (FOLFOX). Testing of … remained favorable regardless of treatment assignment, with five …

… from Zhongshan Golden Bridge Biotechnology (China). Immunohistochemical … collected from two independent medical centers, the sample … cancer patients treated with oxaliplatin-based adjuvant chemotherapy. … for targeted therapeutic treatment in human cancer. …

… self-renewal capacities and drug resistance mechanisms of CSCs. … such as 5-fluorouracil and oxaliplatin. Such observations underscore ALKBH5 … researchcancer stemness and chemoresistancecancer treatment relapse preventionepitranscriptomic modifications in …

… Richard Markus, MD, chief medical officer of Arcus Biosciences, … open-label, phase 3 trial evaluating domvanalimab plus zimberelimab … 4 weeks and FOLFOX (oxaliplatin, leucovorin, fluorouracil) every … survival as first-line treatment of unresectable or …

… drug infusion should be discontinued and appropriate medical treatment should … al. Phase III trial of ipilimumab combined with … analysis of randomized controlled trials. Int Immunopharmacol. … strategy for mitigation of oxaliplatin hypersensitivity. Clin Color …

… drugs are associated with colorectal cancer treatment. Simvastatin, a kind of statin … The first-line treatment drugs for colorectal cancer include capecitabine, oxaliplatin, bevacizumab, etc … are also very useful in medical treatment. Viruses can induce GSDME- …